T he ad that Hims & Hers Health plans to air during the Super Bowl comes at you with rapid-fire visual overload—a giant jiggling belly, bare feet on scales, X-ray results, sugary sodas, a pie in ...

Hims & Hers Health (NYSE: HIMS), a telehealth platform, experienced an 8% increase in its stock on Friday, May 30th, following the announcement of a 4% reduction in its workforce.

Nevertheless, Hims & Hers’ projection for Q2 revenue, with a midpoint of $540 million, fell short of the $565 million consensus forecast. Looking further into the future, the company offered ...